Mercury Laboratories quarterly results and financials

Mercury Laboratories (BSE 538964)₹734.30−2.09%(9 Nov 2026 close)Pharmaceuticals

Key facts

In the Jun 2026 quarter (standalone), Mercury Laboratories reported sales of ₹15.91 Cr, down 12.0% from Jun 2025, and net profit of ₹0.29 Cr, down 69.8% year on year. For the year to Mar 2026, sales were ₹75.76 Cr and net profit ₹4.81 Cr.

Sales (Jun 2026): ₹15.91 Cr
Net profit (Jun 2026): ₹0.29 Cr
Sales (FY Mar 2026): ₹75.76 Cr
Net profit (FY Mar 2026): ₹4.81 Cr
EPS (Jun 2026): ₹2.49
Borrowings (Mar 2026): ₹8.44 Cr

Company filings, standalone accounts; latest reported quarter Jun 2026

Mercury Laboratories quarterly results

₹ crore unless stated; each column is a quarter.

Mercury Laboratories Quarterly results
	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	22.69	17.07	17.32	16.64	18.14	19.51	20.59	18.08	18.97	18.30	20.39	15.91
Expenses	20.33	14.92	14.74	15.11	16.90	17.63	18.57	15.81	16.91	15.87	18.44	14.81
Operating Profit	2.49	2.24	2.67	1.62	1.32	1.99	2.14	2.37	2.14	2.53	2.05	1.20
OPM %	10.9%	13.0%	15.3%	9.7%	7.2%	10.2%	10.3%	13.1%	11.2%	13.7%	10.0%	7.5%
Other Income	0.37	0.19	0.42	0.16	0.22	0.54	0.19	0.19	0.80	−0.09	0.68	0.06
Interest	0.12	0.11	0.11	0.15	0.16	0.14	0.14	0.16	0.14	0.15	0.14	0.13
Depreciation	0.72	0.73	0.73	0.71	0.72	0.75	0.74	0.85	0.87	0.88	0.85	0.74
Profit before tax	2.03	1.58	2.24	0.91	0.65	1.63	1.44	1.54	1.92	1.44	1.75	0.40
Tax %	25.7%	22.0%	15.1%	63.1%	22.7%	27.4%	23.4%	37.4%	14.5%	30.7%	29.3%	23.1%
Exceptional items	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit	1.50	1.23	1.90	0.33	0.49	1.18	1.10	0.96	1.63	0.99	1.22	0.29
EPS (Rs)	12.55	10.31	15.86	2.82	4.16	9.89	9.22	8.06	13.63	8.30	10.22	2.49

Mercury Laboratories profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Mercury Laboratories Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	47.39	47.88	51.75	55.36	57.09	68.43	57.73	75.08	75.36	74.84	75.76	73.57
Expenses	41.11	41.39	47.51	49.87	51.18	59.09	50.98	66.90	66.64	68.23	67.04	66.03
Operating Profit	6.50	6.74	4.44	5.76	6.19	9.62	7.03	8.63	9.06	7.05	9.07	7.92
OPM %	13.6%	14.0%	8.5%	10.3%	10.8%	14.0%	12.1%	11.5%	11.9%	9.4%	11.9%	10.8%
Other Income	0.79	0.36	0.43	1.05	0.86	0.89	0.95	1.70	1.10	1.08	1.58	1.45
Interest	1.14	0.90	0.92	1.10	0.83	0.65	0.46	0.37	0.39	0.56	0.55	0.56
Depreciation	1.19	1.30	1.48	1.64	1.88	1.93	2.46	2.49	2.83	2.89	3.43	3.34
Profit before tax	4.93	4.90	2.45	4.04	4.32	7.90	5.05	7.46	6.91	4.65	6.65	5.51
Tax %	20.4%	44.8%	17.9%	29.9%	25.4%	32.5%	29.1%	25.0%	18.3%	32.6%	27.1%	—
Exceptional items	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit	3.91	2.69	2.00	2.83	3.22	5.32	3.55	5.56	5.63	3.13	4.81	4.13
EPS (Rs)	32.57	22.42	16.71	23.61	26.85	44.34	29.58	46.32	46.90	26.07	40.13	34.64
Dividend payout %	4.6%	6.7%	9.0%	6.4%	7.4%	7.9%	11.8%	7.5%	7.4%	13.4%	8.7%	—

Mercury Laboratories balance sheet

₹ crore, at each year end.

Mercury Laboratories Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	1.19	1.19	1.19	1.19	1.19	1.19	1.19	1.19	1.19	1.19	1.19	1.19
Reserves	16.87	20.56	23.19	25.05	27.67	30.68	35.54	38.95	44.28	49.44	52.17	56.68
Borrowings	8.91	7.39	7.46	9.78	9.58	7.20	7.11	6.00	5.84	5.56	5.47	8.44
Other Liabilities	15.46	17.24	19.17	15.54	18.71	17.08	21.32	16.14	12.65	11.62	15.27	12.61
Total Liabilities	42.43	46.38	51.01	51.56	57.15	56.15	65.16	62.28	63.96	67.81	74.10	78.92
Fixed Assets	19.46	18.55	18.36	20.73	24.37	23.63	26.30	25.77	24.22	24.00	24.61	23.84
CWIP	0.00	0.00	0.41	0.25	0.00	0.00	0.00	0.00	0.14	3.83	9.34	9.85
Investments	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02
Other Assets	22.95	27.81	32.22	30.56	32.76	32.50	38.84	36.49	39.58	39.96	40.13	45.21
Inventories	4.37	6.41	7.59	7.66	6.76	5.50	5.14	6.76	6.87	6.19	7.18	7.10
Trade receivables	12.12	13.36	17.46	14.66	19.20	18.07	22.45	16.68	21.28	21.76	25.64	25.74
Cash & equivalents	1.18	1.28	1.45	3.80	1.49	2.52	4.88	6.94	7.33	8.24	2.20	6.19
Total Assets	42.43	46.38	51.01	51.56	57.15	56.15	65.16	62.28	63.96	67.81	74.10	78.92

Mercury Laboratories cash flow

₹ crore, for each year.

Mercury Laboratories Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	3.50	−0.11	1.93	4.98	5.23	5.50	8.23	5.20	2.46	8.25	4.01	4.25
Cash from investing activity	−1.55	−0.27	−1.49	−3.67	−4.98	−1.15	−4.61	−1.88	−1.05	−6.26	−9.03	−3.18
Cash from financing activity	−2.11	0.46	−0.24	1.06	−2.53	−3.32	−1.23	−1.22	−1.00	−1.03	−0.98	2.62
Net cash flow	−0.17	0.08	0.16	2.35	−2.30	1.01	2.35	2.06	0.37	0.90	−6.02	3.70
Capex	1.55	0.27	1.51	3.71	4.98	1.15	4.63	1.92	1.07	6.28	9.03	3.18
Free cash flow	1.96	−0.39	0.43	1.30	0.24	4.36	3.60	3.31	1.40	1.97	−5.05	1.08
CFO / OP %	82.0%	20.0%	45.0%	129.0%	109.0%	109.0%	100.0%	101.0%	41.0%	105.0%	91.0%	61.0%

Mercury Laboratories ratios

Working-capital days and returns, by year.

Mercury Laboratories Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	109	104	134	105	128	117	121	106	105	107	126	125
Inventory days	94	116	137	120	94	78	60	105	83	76	92	88
Days payable	159	136	187	139	162	120	138	106	77	63	126	77
Cash conversion cycle	42	82	84	85	59	74	42	104	110	118	92	135
Working capital days	9	47	103	91	89	89	75	79	87	92	111	130
ROCE %	21.3%	21.6%	18.9%	9.8%	13.8%	13.3%	20.6%	11.8%	16.0%	13.4%	9.0%	12.1%

Mercury Laboratories: frequently asked questions

What are the latest quarterly results of Mercury Laboratories?

For the Jun 2026 quarter, Mercury Laboratories reported sales of ₹15.91 Cr, down 12.0% year on year and net profit of ₹0.29 Cr, down 69.8% year on year. The operating margin was 7.5%.

What is the annual revenue of Mercury Laboratories?

Mercury Laboratories' sales for the year to Mar 2026 were ₹75.76 Cr; over the last twelve months they were ₹73.57 Cr.

What is the net profit of Mercury Laboratories?

Net profit for the year to Mar 2026 was ₹4.81 Cr, and ₹4.13 Cr over the last twelve months. Earnings per share over the same trailing period were ₹34.64.

How much debt does Mercury Laboratories have?

Mercury Laboratories reported borrowings of ₹8.44 Cr at Mar 2026, against cash and equivalents of ₹6.19 Cr.

What is the free cash flow of Mercury Laboratories?

Cash from operations was ₹4.25 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹1.08 Cr.

Loading…